Katsumasa Nakajima

机构：Center for Global Development, Novartis (United States) · ORCID：0000-0001-8295-5086

发表论文 47 篇 · 总被引 1129 次 · h-index 17

代表论文

• Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant Cancers (2018 · Journal of Medicinal Chemistry · 被引 241)
• Asymmetric Ni(II)/Cr(II)-Mediated Coupling Reaction:  Stoichiometric Process (2002 · Organic Letters · 被引 92)
• Synthetic studies on the marine natural product halichondrins (2003 · Pure and Applied Chemistry · 被引 71)
• Tandem Conjugate Additions and 3-Aza-Cope Rearrangements of Tertiary Allyl Amines and Cyclic α-Vinylamines with Acetylenic Sulfones. Applications to Simple and Iterative Ring Expansions Leading to Medium and Large-Ring Nitrogen Heterocycles (2008 · The Journal of Organic Chemistry · 被引 64)
• Identification of a PCSK9-LDLR disruptor peptide with in vivo function (2021 · Cell chemical biology · 被引 50)
• The Discovery of SWI/SNF Chromatin Remodeling Activity as a Novel and Targetable Dependency in Uveal Melanoma (2020 · Molecular Cancer Therapeutics · 被引 39)